Clinical Trial: Phase 1 Clinical Study of MWN110 Injection in Healthy Participants and Overweight or Obese Participants

U.S., Aug. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07779980) titled 'Phase 1 Clinical Study of MWN110 Injection in Healthy Participants and Overweight or Obese Participants' on Aug. 14.

Brief Summary: This study is a multicenter, randomized, double-blind, placebo-controlled, single and multiple ascending-dose phase 1 clinical trial aimed at evaluating the safety, tolerability, PK, PD, and immunogenicity of MWN110 Injection in healthy participants and overweight or obese participants.

The study consists of two parts: Part 1, a single ascending dose (SAD) study in healthy participants with 8 dose cohorts; and Part 2, a multiple ascending dose (MAD) study in overweight or obese participants with 3 dose...